Month: November 2020
-
Personal Cancer Vaccine Induces Tumor Shrinkage
Interim results from a clinical trial show some head and neck cancer patients receiving a personalized vaccine and immunotherapy report tumor shrinkage.
-
Coronavirus Antibody Maker Raises $80M in New Funds
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds.
-
Salk, Energy Utility Partner on Carbon Capture Plants
A California energy utility and Salk Institute are collaborating on engineering new plant varieties that capture and store more carbon dioxide in the ground.
-
FDA Issues Guidance to Boost Clinical Trial Diversity
Food and Drug Administration issued new regulatory guidance designed to enroll clinical trial participants more representative of the populations they claim to serve.
-
Electric Crispr Chip Quickly Detects Covid-19 Virus
An engineering lab developed a chip device that uses gene editing and an electric field to detect viruses responsible for Covid-19 infections.
-
Future Proof Job Roles
Searching for a future proof role for your working life can help you to avoid being forced into the decision further down the line.
-
Infographic – U.S. Public Split on Contact Tracing
While majorities of Americans say they’re willing to take part in contact tracing activities during the Covid-19 pandemic, large parts of the public are still reluctant.
-
Oral Drug Delivery Company Acquired in $1.8B Deal
Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk.
-
Diabetes Foundation, Lilly Invest in Protein Biotech
A biotechnology company creating synthetic sensing proteins received equity investments to support work on its variable-release insulin for people with type 1 diabetes.
-
Online App Encourages Abstinence in Alcohol Addiction
Results from a clinical trial show users of an online abstinence training app are less likely to relapse in alcohol consumption than sham training app users.